Highly multiplexed imaging by Cyclic Immunofluorescence (CycIF) of protein levels and protein phosphorylation states in the COLO 858 melanoma cell line - Dataset (ID:20236)

Filter results: >>>>
Cell Small Molecule Small Mol Concentration Small Mol Conc Unit Timepoint Timepoint Unit Raw Image Registered Image CycIF Round Primary Antibody Secondary Antibody Cytell filter Protein Detected Other Reagent Detected Measured Fluorescence Intensity (a.u.) Field Cell ID Number X-coordinate Y-coordinate Cell Area (um^2) Cell Perimeter (um) Cell Circularity
COLO 858 Vemurafenib
0.1
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 1815.0 3
0245-0621
358.11 621.50 605 95.40 0.835
COLO 858 Vemurafenib
0.1
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 302.9 3
0246-0620
736.77 620.01 369 81.98 0.690
COLO 858 Vemurafenib
0.1
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 594.2 3
0247-0619
389.04 619.47 348 72.08 0.842
COLO 858 Vemurafenib
0.1
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 446.4 3
0248-0626
210.28 626.97 308 71.36 0.760
COLO 858 Vemurafenib
0.1
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 316.7 3
0249-0631
692.35 631.02 357 79.98 0.701
COLO 858 Vemurafenib
0.1
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 598.2 3
0250-0632
846.96 632.32 249 57.36 0.951
COLO 858 Vemurafenib
0.1
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 369.6 3
0251-0636
620.94 636.44 368 73.01 0.867
COLO 858 Vemurafenib
0.1
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 330.7 3
0252-0638
328.05 638.02 417 85.15 0.723
COLO 858 Vemurafenib
0.1
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 419.3 3
0253-0642
35.07 642.13 314 71.01 0.782
COLO 858 Vemurafenib
0.1
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 410.0 3
0254-0643
168.48 643.62 337 71.50 0.828
COLO 858 Vemurafenib
0.1
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 751.8 3
0255-0645
212.27 643.20 363 77.60 0.758
COLO 858 Vemurafenib
0.1
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 723.7 3
0256-0650
129.25 650.17 437 81.74 0.822
COLO 858 Vemurafenib
0.1
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 570.5 3
0257-0649
798.87 649.68 206 73.50 0.479
COLO 858 Vemurafenib
0.1
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 374.8 3
0258-0654
92.12 653.99 352 70.67 0.886
COLO 858 Vemurafenib
0.1
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 355.2 3
0259-0653
558.56 653.05 375 73.84 0.864
COLO 858 Vemurafenib
0.1
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 2350.3 3
0260-0653
675.92 653.29 342 73.84 0.788
COLO 858 Vemurafenib
0.1
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 392.7 3
0261-0659
342.21 659.10 369 83.98 0.657
COLO 858 Vemurafenib
0.1
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 396.3 3
0262-0660
203.39 661.36 396 79.98 0.778
COLO 858 Vemurafenib
0.1
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 337.1 3
0263-0663
904.83 662.51 330 69.26 0.865
COLO 858 Vemurafenib
0.1
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 297.5 3
0264-0667
947.34 667.52 341 73.84 0.786
COLO 858 Vemurafenib
0.1
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 2226.5 3
0265-0669
683.59 669.86 372 78.43 0.760
COLO 858 Vemurafenib
0.1
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 326.9 3
0266-0674
610.07 674.02 369 74.91 0.826
COLO 858 Vemurafenib
0.1
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 637.0 3
0267-0672
488.26 672.92 362 72.67 0.861
COLO 858 Vemurafenib
0.1
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 393.3 3
0268-0675
720.71 675.02 357 74.67 0.805
COLO 858 Vemurafenib
0.1
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 1385.6 3
0269-0685
89.67 685.35 313 65.60 0.914